BCL2 and breast carcinoma: The stability of anti-apoptotic proteins Mcl-1 and Bcl-2 was also assessed in these MDA-MB-468, MDA-MB-231 and MCF-7 breast cancer cells after treatment with CHX (200 μg ml–1).